Cargando…
Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson’s Disease?
Parkinson’s disease (PD) is a slowly progressing neurodegenerative disorder that is coupled to both widespread protein aggregation and to loss of substantia nigra dopamine (DA) neurons, resulting in a wide variety of motor and non-motor signs and symptoms. Recent findings suggest that the PD process...
Autores principales: | von Linstow, Christian U., DeLano-Taylor, Merritt, Kordower, Jeffrey H., Brundin, Patrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242832/ https://www.ncbi.nlm.nih.gov/pubmed/31958098 http://dx.doi.org/10.3233/JPD-191877 |
Ejemplares similares
-
Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
por: von Linstow, Christian U., et al.
Publicado: (2020) -
Differences in Number of Midbrain Dopamine Neurons Associated with Summer and Winter Photoperiods in Humans
por: Aumann, Tim D., et al.
Publicado: (2016) -
Reliability in the Identification of Midbrain Dopamine Neurons
por: Margolis, Elyssa B., et al.
Publicado: (2010) -
Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease
por: Hiller, Benjamin M., et al.
Publicado: (2022) -
Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease
por: Li, Yanxuan, et al.
Publicado: (2020)